Biblio

Filters: Author is Bateman, John F [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

Kung LHW, Sampurno L, Yammine KM, Graham A, McDonald P, Bateman JF, Shoulders MD, Lamandé SR. CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A. Stem Cell Res. 2020;48:101962.

G

Far HHosseini, Patria YNur, Motazedian A, Elefanty AG, Stanley EG, Lamandé SR, Bateman JF. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing. Stem Cell Res. 2019;37:101449.

Lilianty J, Bateman JF, Lamandé SR. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing. Stem Cell Res. 2021;56:102515.

Lilianty J, Patria YNur, Stanley EG, Elefanty AG, Bateman JF, Lamandé SR. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing. Stem Cell Res. 2020;45:101843.

Kung LHW, Sampurno L, Little CB, Lamandé SR, Bateman JF. Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing. Stem Cell Res. 2020;50:102118.